Nomifensine (Nomifensin)
An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
Also Known As:
Nomifensin; Hoe-984; Linamiphen; Merital; Nomifensine Maleate; Nomifensine Maleate (1:1); Hoe 984; Hoe984; Maleate, Nomifensine; 8-Isoquinolinamine, 1,2,3,4-tetrahydro-2-methyl-4-phenyl-
Networked: 194
relevant articles (5 outcomes,
18 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Bai, Hyoung-Woo:
1 article
(04/2022)
|
2. | Bak, Dong-Ho:
1 article
(04/2022)
|
3. | Kang, Seong Hee:
1 article
(04/2022)
|
4. | Yeoup Chung, Byung:
1 article
(04/2022)
|
5. | Petrić, Aleksandra:
1 article
(06/2014)
|
6. | Radović-Janosević, Dragana:
1 article
(06/2014)
|
7. | Stefanović, Milan:
1 article
(06/2014)
|
8. | Tubić-Pavlović, Aleksandra:
1 article
(06/2014)
|
9. | Fadel, J:
1 article
(08/2013)
|
10. | Martins, I:
1 article
(08/2013)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures